Seyed-Mahdi Khaligh-Razavi

Founder presso COGNETIVITY NEUROSCIENCES LTD.

Patrimonio netto: 107 696 $ in data 31/03/2024

35 anni

Health Technology

Consumer Services

Profilo

Seyed-Mahdi Khaligh-Razavi is the founder and the Chief Innovation Officer at Cognetivity Neurosciences Ltd., a company founded in 2019.
He is also the founder and the Chief Innovation Officer at Cognetivity Ltd., a company founded in 2013.
Dr. Khaligh-Razavi holds a doctorate degree from the University of Cambridge, which was conferred in 2014.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
COGNETIVITY NEUROSCIENCES LTD. 8.59%	18/03/2024	7 692 565 ( 8.59% )	107 696 $	31/03/2024

Posizioni attive di Seyed-Mahdi Khaligh-Razavi

Società	Posizione	Inizio
COGNETIVITY NEUROSCIENCES LTD.	Founder	08/01/2019
Cognetivity Ltd. Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom.	Founder	10/04/2013

Tutte le posizioni attive di Seyed-Mahdi Khaligh-Razavi

Formazione di Seyed-Mahdi Khaligh-Razavi

University of Cambridge

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Seyed-Mahdi Khaligh-Razavi

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
COGNETIVITY NEUROSCIENCES LTD.	Health Technology

Aziende private	1
Cognetivity Ltd. Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom.	Health Technology